Get started
Author

Thomai Tsapanou-Katranara

Observed names: T Katranara Tsapanou, T Tsapanou Katranara, T. Tsapanou-Katranara
ORCID: 0009-0006-2813-298X
Observed ORCID: 0009-0006-2813-298X
OpenAlex ID: A5114715508
Serum biomarkers of collagen remodeling are associated with intestinal fibrosis and differentiate stenotic from luminal Crohn’s disease patients: a pre- and post-resection longitudinal study
2025 · Anja Poulsen, Marta Sorokina Alexdóttir, et al. · Journal of Crohn s and Colitis · 7
PDF
Neutrophil-mediated degradation of type III collagen is elevated in inflammatory bowel disease and DSS-induced colitis reflecting early mucosal damage
2025 · Thomai Tsapanou-Katranara, Marta S. Alexdottir, et al. · Scientific Reports · 5
PDF
Su1512 EXTRACELLULAR MATRIX BIOMARKERS MAY AID IN CHOICE OF ADVANCED THERAPY SEQUENCING TO VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE
2026 · Camilla Frimor, Marta Sorokina Alexdóttir, et al. · Gastroenterology
Sa1544 EXTRACELLULAR MATRIX-DERIVED BIOMARKERS OF MUCOSAL DAMAGE AND NEUTROPHIL ACTIVITY ARE ASSOCIATED WITH VEDOLIZUMAB FAILURE IN ANTI-TNF EXPERIENCED PATIENTS WITH ULCERATIVE COLITIS
2026 · Marta Sorokina Alexdóttir, Camilla Frimor, et al. · Gastrointestinal Endoscopy
Su1510 ENDOTROPHIN-DERIVED PRO-C6 IDENTIFIES A FIBROTIC PHENOTYPE IN CROHN’S DISEASE
2026 · Anja Poulsen, Marta Sorokina Alexdóttir, et al. · Gastrointestinal Endoscopy
Sa1543 BIOMARKERS OF NEUTROPHIL AND MACROPHAGE ACTIVITY DISCRIMINATE NON-IBD FROM CROHNߵS DISEASE AND ASSOCIATE WITH ENDOSCOPIC DISEASE ACTIVITY
2026 · Marta Sorokina Alexdóttir, Jacob Broder Brodersen, et al. · Gastroenterology
Sa1544 EXTRACELLULAR MATRIX-DERIVED BIOMARKERS OF MUCOSAL DAMAGE AND NEUTROPHIL ACTIVITY ARE ASSOCIATED WITH VEDOLIZUMAB FAILURE IN ANTI-TNF EXPERIENCED PATIENTS WITH ULCERATIVE COLITIS
2026 · Marta Sorokina Alexdóttir, Camilla Frimor, et al. · Gastroenterology
Su1513 EXTRACELLULAR MATRIX BIOMARKERS MAY AID CHOICE OF ADVANCED THERAPY SEQUENCING TO VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS
2026 · Camilla Frimor, Marta Sorokina Alexdóttir, et al. · Gastroenterology
Sa1460 C7M, A MARKER OF TYPE VII COLLAGEN DEGRADATION, IS REFLECTIVE OF EPITHELIAL REMODELING AND IS STRONGLY ASSOCIATED WITH INTESTINAL MUCOSAL DAMAGE IN CROHN’S DISEASE.
2026 · Joachim Høg Mortensen, Anja Poulsen, et al. · Gastroenterology
Sa1543 BIOMARKERS OF NEUTROPHIL AND MACROPHAGE ACTIVITY DISCRIMINATE NON-IBD FROM CROHNߵS DISEASE AND ASSOCIATE WITH ENDOSCOPIC DISEASE ACTIVITY
2026 · Marta Sorokina Alexdóttir, Jacob Broder Brodersen, et al. · Gastrointestinal Endoscopy
Sa1593 SEROLOGICAL BIOMARKERS OF COLLAGEN FORMATION AND IMMUNE CELL ACTIVITY REFLECT FIBROSTENOTIC STRICTURES AND FISTULA IN PATIENTS WITH CROHN’S DISEASE – IBSEN III STUDY.
2026 · Joachim Høg Mortensen, Ida Frivold Glad, et al. · Gastroenterology
Sa1593 SEROLOGICAL BIOMARKERS OF COLLAGEN FORMATION AND IMMUNE CELL ACTIVITY REFLECT FIBROSTENOTIC STRICTURES AND FISTULA IN PATIENTS WITH CROHN’S DISEASE – IBSEN III STUDY.
2026 · Joachim Høg Mortensen, Ida Frivold Glad, et al. · Gastrointestinal Endoscopy
Su1510 ENDOTROPHIN-DERIVED PRO-C6 IDENTIFIES A FIBROTIC PHENOTYPE IN CROHN’S DISEASE
2026 · Anja Poulsen, Marta Sorokina Alexdóttir, et al. · Gastroenterology
Su1512 EXTRACELLULAR MATRIX BIOMARKERS MAY AID IN CHOICE OF ADVANCED THERAPY SEQUENCING TO VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE
2026 · Camilla Frimor, Marta Sorokina Alexdóttir, et al. · Gastrointestinal Endoscopy
Su1516 MARKERS OF ECM REMODELING AND WOUND HEALING ARE ASSOCIATED WITH FIBROSTENOTIC CROHN DISEASE
2026 · Letizia Satriano, Lucie Auffret, et al. · Gastroenterology
Sa1460 C7M, A MARKER OF TYPE VII COLLAGEN DEGRADATION, IS REFLECTIVE OF EPITHELIAL REMODELING AND IS STRONGLY ASSOCIATED WITH INTESTINAL MUCOSAL DAMAGE IN CROHN’S DISEASE.
2026 · Joachim Høg Mortensen, Anja Poulsen, et al. · Gastrointestinal Endoscopy
Su1513 EXTRACELLULAR MATRIX BIOMARKERS MAY AID CHOICE OF ADVANCED THERAPY SEQUENCING TO VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS
2026 · Camilla Frimor, Marta Sorokina Alexdóttir, et al. · Gastrointestinal Endoscopy
Su1516 MARKERS OF ECM REMODELING AND WOUND HEALING ARE ASSOCIATED WITH FIBROSTENOTIC CROHN DISEASE
2026 · Letizia Satriano, Lucie Auffret, et al. · Gastrointestinal Endoscopy
Increased remodeling of type XXII collagen is associated with an inflammatory phenotype in Crohn’s disease
2026 · Marta S. Alexdottir, Arno R. Bourgonje, et al. · Scientific Reports
PDF
P0152 Macrophage- and CD8+ T cell-conditioned media induce fibrogenesis, measured via type VI and I collagen formation, in a gastrointestinal Scar-in-a-Jar model
2026 · T Tsapanou Katranara, A Benito-Agustino, et al. · Journal of Crohn s and Colitis
PDF
P0370 Biomarkers of neutrophil and macrophage activity discriminate non-Inflammatory Bowel Disease from Crohn’s Disease and associate with endoscopic disease activity
2026 · M Sorokina Alexdóttir, J Brodersen, et al. · Journal of Crohn s and Colitis
P0249 Markers of extracellular matrix remodeling and wound healing are associated with fibrostenotic Crohn Disease
2026 · L Satriano, L Auffret, et al. · Journal of Crohn s and Colitis
P1076 Extracellular matrix-derived biomarkers of mucosal damage and neutrophil activity are associated with vedolizumab failure in anti-TNF experienced patients with Ulcerative Colitis
2026 · M Sorokina Alexdóttir, C Frimor, et al. · Journal of Crohn s and Colitis
P1161 Extracellular matrix biomarkers may aid choice of advanced therapy sequencing to vedolizumab in patients with ulcerative colitis
2026 · C Frimor, M Sorokina Alexdóttir, et al. · Journal of Crohn s and Colitis
PDF
P1013 Extracellular matrix biomarkers may aid in choice of advanced therapy sequencing to vedolizumab in patients with Crohn’s disease
2026 · C Frimor, M Sorokina Alexdóttir, et al. · Journal of Crohn s and Colitis
PDF
Works count: 33
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type